Exelixis
$22.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$22.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.82 (+3.85%) Today
-$0.14 (-0.63%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Exelixis and other stocks, options, and ETFs commission-free!
About EXEL
Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA. The listed name for EXEL is Exelixis, Inc. Common Stock.
CEO
Michael M. Morrissey
Employees
617
Headquarters
Alameda, California
Founded
1994
Market Cap
7.16B
Price-Earnings Ratio
46.27
Dividend Yield
—
Average Volume
3.31M
High Today
$22.29
Low Today
$21.13
Open Price
$21.24
Volume
3.73M
52 Week High
$27.80
52 Week Low
$13.67
Collections
Analyst Ratings
75%
of 12 ratings
Buy
75%
Hold
25%
Sell
0%
EXEL Earnings
$0.00
$0.11
$0.23
$0.34
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 10, After Hours